位置:首页 > 蛋白库 > SUBA_ECOLX
SUBA_ECOLX
ID   SUBA_ECOLX              Reviewed;         347 AA.
AC   Q6EZC2;
DT   28-MAR-2018, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   03-AUG-2022, entry version 80.
DE   RecName: Full=Subtilase cytotoxin subunit A {ECO:0000303|PubMed:15226357};
DE            EC=3.4.21.- {ECO:0000269|PubMed:17024087};
DE   Flags: Precursor;
GN   Name=subA {ECO:0000303|PubMed:15226357};
OS   Escherichia coli.
OG   Plasmid megaplasmid pO113.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=O113:H21 / 98NK2 / STEC; PLASMID=megaplasmid pO113;
RX   PubMed=11598075; DOI=10.1128/iai.69.11.6999-7009.2001;
RA   Paton A.W., Srimanote P., Woodrow M.C., Paton J.C.;
RT   "Characterization of Saa, a novel autoagglutinating adhesin produced by
RT   locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli
RT   strains that are virulent for humans.";
RL   Infect. Immun. 69:6999-7009(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=O29;
RX   PubMed=17101670; DOI=10.1128/iai.01336-06;
RA   Morinaga N., Yahiro K., Matsuura G., Watanabe M., Nomura F., Moss J.,
RA   Noda M.;
RT   "Two distinct cytotoxic activities of subtilase cytotoxin produced by
RT   Shiga-toxigenic Escherichia coli.";
RL   Infect. Immun. 75:488-496(2007).
RN   [3]
RP   PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, PUTATIVE ACTIVE SITE, SUBUNIT,
RP   SUBCELLULAR LOCATION, OPERON, DISRUPTION PHENOTYPE, BIOTECHNOLOGY, AND
RP   MUTAGENESIS OF SER-272.
RC   STRAIN=O113:H21 / 98NK2 / STEC; PLASMID=megaplasmid pO113;
RX   PubMed=15226357; DOI=10.1084/jem.20040392;
RA   Paton A.W., Srimanote P., Talbot U.M., Wang H., Paton J.C.;
RT   "A new family of potent AB(5) cytotoxins produced by Shiga toxigenic
RT   Escherichia coli.";
RL   J. Exp. Med. 200:35-46(2004).
RN   [4]
RP   ERRATUM OF PUBMED:15226357.
RX   DOI=10.1084/jem.20040392111204c;
RA   Paton A.W., Srimanote P., Talbot U.M., Wang H., Paton J.C.;
RT   "A new family of potent AB(5) cytotoxins produced by Shiga toxigenic
RT   Escherichia coli.";
RL   J. Exp. Med. 200:1525-1525(2004).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18042253; DOI=10.1111/j.1462-5822.2007.01085.x;
RA   Chong D.C., Paton J.C., Thorpe C.M., Paton A.W.;
RT   "Clathrin-dependent trafficking of subtilase cytotoxin, a novel AB5 toxin
RT   that targets the endoplasmic reticulum chaperone BiP.";
RL   Cell. Microbiol. 10:795-806(2008).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-272.
RX   PubMed=18005237; DOI=10.1111/j.1462-5822.2007.01094.x;
RA   Morinaga N., Yahiro K., Matsuura G., Moss J., Noda M.;
RT   "Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli,
RT   transiently inhibits protein synthesis of Vero cells via degradation of BiP
RT   and induces cell cycle arrest at G1 by downregulation of cyclin D1.";
RL   Cell. Microbiol. 10:921-929(2008).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF SER-272.
RX   PubMed=18433465; DOI=10.1111/j.1462-5822.2008.01164.x;
RA   Wolfson J.J., May K.L., Thorpe C.M., Jandhyala D.M., Paton J.C.,
RA   Paton A.W.;
RT   "Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum
RT   stress-signalling pathways.";
RL   Cell. Microbiol. 10:1775-1786(2008).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF SER-272.
RX   PubMed=19380466; DOI=10.1128/iai.01510-08;
RA   Matsuura G., Morinaga N., Yahiro K., Komine R., Moss J., Yoshida H.,
RA   Noda M.;
RT   "Novel subtilase cytotoxin produced by Shiga-toxigenic Escherichia coli
RT   induces apoptosis in Vero cells via mitochondrial membrane damage.";
RL   Infect. Immun. 77:2919-2924(2009).
RN   [9] {ECO:0007744|PDB:2IY9}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), DISULFIDE BONDS, FUNCTION,
RP   SUBSTRATE SPECIFICITY, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, DOMAIN,
RP   AND MUTAGENESIS OF SER-272.
RX   PubMed=17024087; DOI=10.1038/nature05124;
RA   Paton A.W., Beddoe T., Thorpe C.M., Whisstock J.C., Wilce M.C.,
RA   Rossjohn J., Talbot U.M., Paton J.C.;
RT   "AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone
RT   BiP.";
RL   Nature 443:548-552(2006).
RN   [10] {ECO:0007744|PDB:4BWG}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH SUBB, SUBUNIT,
RP   SUBCELLULAR LOCATION, DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=23921389; DOI=10.1074/jbc.m113.462622;
RA   Le Nours J., Paton A.W., Byres E., Troy S., Herdman B.P., Johnson M.D.,
RA   Paton J.C., Rossjohn J., Beddoe T.;
RT   "Structural basis of subtilase cytotoxin SubAB assembly.";
RL   J. Biol. Chem. 288:27505-27516(2013).
CC   -!- FUNCTION: Protease subunit of subtilase cytotoxin SubAB5
CC       (PubMed:17024087). An endoprotease specific for host endoplasmic
CC       reticulum (ER) chaperone BiP/HSPA5, has no activity on human HSP70 or
CC       HSPA8 (PubMed:17024087). Cleaves between 'Leu-416' and 'Leu-417' of
CC       BiP/HSPA5 in the hinge between BiP's ATPase and protein-binding domains
CC       (PubMed:17024087). This induces host ER stress response and eventual
CC       cell death (PubMed:18005237, PubMed:18433465). Culture supernatant of
CC       E.coli expressing both subA and subB are toxic for Vero cells (African
CC       green monkey kidney cell line), Chinese hamster ovary cells and Hct-8
CC       cells (human colonic epithelial cell line); the subunits are not toxic
CC       individually (PubMed:15226357). Purified SubAB5 is highly toxic, <0.1
CC       pg is able to kill at least 50% of 30'000 Vero cells in a microtiter
CC       plate assay after 3 days; no cytotoxicity is seen at 24 hours
CC       (PubMed:15226357). Preabsorption with cells expressing a ganglioside
CC       GM2 mimic reduced cytotoxicity of SubAB5 by 93% in the Vero
CC       cytotoxicity assay (PubMed:15226357). Intraperitoneal injection of 200
CC       ng of purified SubAB5 kills mice; the higher the dose the faster the
CC       mice die. Animals injected intraperitoneally with purified SubAB5 have
CC       microvascular thrombi in the brain and other organs, including the
CC       renal tubules and glomeruli (PubMed:15226357). Injection induces an
CC       unfolded response in mice (PubMed:17024087). Mice fed E.coli cells
CC       expressing cloned SubAB5 experience drastic weight loss and appear ill
CC       and lethargic (PubMed:15226357). Protein synthesis in Vero cells is
CC       transiently inhibited by SubAB5; both subunits are required for this
CC       effect (PubMed:17101670, PubMed:18005237, PubMed:18433465). Inhibition
CC       of protein synthesis is prevented by brefeldin A; cells are arrested in
CC       the G1 phase (PubMed:18005237). SubAB5 at 100 ng/ml induced caspase-
CC       dependent apoptosis in Vero cells through mitochondrial membrane damage
CC       (PubMed:19380466). {ECO:0000269|PubMed:15226357,
CC       ECO:0000269|PubMed:17024087, ECO:0000269|PubMed:17101670,
CC       ECO:0000269|PubMed:18005237, ECO:0000269|PubMed:18433465,
CC       ECO:0000269|PubMed:19380466}.
CC   -!- SUBUNIT: Forms a complex with SubB with the stoichiometry SubA1:SubB5
CC       (called SubAB5) (PubMed:15226357, PubMed:23921389).
CC       {ECO:0000269|PubMed:23921389, ECO:0000305|PubMed:15226357}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15226357}. Host
CC       cytoplasm, host cytosol {ECO:0000269|PubMed:15226357,
CC       ECO:0000269|PubMed:17101670}. Host endoplasmic reticulum lumen
CC       {ECO:0000305|PubMed:17024087, ECO:0000305|PubMed:18005237,
CC       ECO:0000305|PubMed:23921389}. Note=Colocalizes with host BiP/HSPA5 in
CC       the endoplasmic reticulum of Vero cells, its activity on BiP/HSPA5 is
CC       blocked by pretreatment with brefeldin A, which disrupts the Golgi
CC       apparatus and inhibits retrograde transport from the cell surface to
CC       the Golgi (PubMed:17024087, PubMed:18005237). Using different
CC       inhibitors it has been shown to be actively internalized by membrane-
CC       bound vesicles and undergoes clathrin-dependent retrograde transport,
CC       via early endosomes and the Golgi network, to the endoplasmic reticulum
CC       (PubMed:18042253). Trafficking is similar in Vero cells, human HeLa
CC       cells and murine N2A cells (PubMed:18042253).
CC       {ECO:0000269|PubMed:15226357, ECO:0000269|PubMed:17024087,
CC       ECO:0000269|PubMed:18005237, ECO:0000269|PubMed:18042253}.
CC   -!- INDUCTION: Part of the subA-subB operon (PubMed:15226357).
CC       {ECO:0000269|PubMed:15226357}.
CC   -!- DOMAIN: The catalytic charge relay system lies at the bottom of a deep
CC       cleft which probably accounts for its substrate specificity
CC       (PubMed:17024087, PubMed:23921389). The C-terminal A2 domain
CC       (approximately residues 322-347) penetrates into the central pore of
CC       the SubB pentamer, making different contacts with each SubB subunit
CC       (PubMed:23921389). {ECO:0000269|PubMed:17024087,
CC       ECO:0000269|PubMed:23921389}.
CC   -!- DISRUPTION PHENOTYPE: No longer toxic to CHO cells when deletion
CC       construct is coexpressed with subB (PubMed:15226357).
CC       {ECO:0000269|PubMed:15226357}.
CC   -!- BIOTECHNOLOGY: Injection of the inactive mutant protein (Ala instead of
CC       ser at position 272) in mice has no deleterious effects and elicits an
CC       antibody response, suggesting it could be used as a vaccine
CC       (PubMed:15226357). {ECO:0000269|PubMed:15226357}.
CC   -!- MISCELLANEOUS: The E.coli strain this operon was isolated from causes
CC       hemolytic uremic syndrome (HUS) and also encodes Stx, a Shigella-type
CC       toxin. {ECO:0000303|PubMed:15226357}.
CC   -!- SIMILARITY: Belongs to the peptidase S8 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF399919; AAT68785.1; -; Genomic_DNA.
DR   PDB; 2IY9; X-ray; 1.80 A; A=1-347.
DR   PDB; 4BWG; X-ray; 2.60 A; A/G=1-347.
DR   PDBsum; 2IY9; -.
DR   PDBsum; 4BWG; -.
DR   AlphaFoldDB; Q6EZC2; -.
DR   SMR; Q6EZC2; -.
DR   DIP; DIP-60412N; -.
DR   IntAct; Q6EZC2; 1.
DR   MEROPS; S08.121; -.
DR   EvolutionaryTrace; Q6EZC2; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044164; C:host cell cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0044166; C:host cell endoplasmic reticulum lumen; IMP:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.200; -; 1.
DR   InterPro; IPR000209; Peptidase_S8/S53_dom.
DR   InterPro; IPR036852; Peptidase_S8/S53_dom_sf.
DR   Pfam; PF00082; Peptidase_S8; 1.
DR   SUPFAM; SSF52743; SSF52743; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS51892; SUBTILASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; Host cytoplasm;
KW   Host endoplasmic reticulum; Hydrolase; Plasmid; Protease; Secreted;
KW   Serine protease; Signal; Toxin; Virulence.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:15226357"
FT   CHAIN           22..347
FT                   /note="Subtilase cytotoxin subunit A"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5004273014"
FT   DOMAIN          24..327
FT                   /note="Peptidase S8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   REGION          322..347
FT                   /note="A2 domain"
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MOTIF           344..347
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        52
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240,
FT                   ECO:0000303|PubMed:15226357"
FT   ACT_SITE        89
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240,
FT                   ECO:0000303|PubMed:15226357"
FT   ACT_SITE        272
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240,
FT                   ECO:0000303|PubMed:15226357"
FT   DISULFID        288..331
FT                   /evidence="ECO:0000269|PubMed:23921389,
FT                   ECO:0007744|PDB:2IY9, ECO:0007744|PDB:4BWG"
FT   VARIANT         263
FT                   /note="A -> G (in strain: O29)"
FT                   /evidence="ECO:0000269|PubMed:17101670"
FT   MUTAGEN         272
FT                   /note="S->A: Reduces cytotoxicity on Vero cells by more
FT                   than 99.9%, no toxic effect on mice when injected as
FT                   purified SubAB5. Does not cleave host BiP/HSPA5 in Vero
FT                   cells nor purified BiP/HSPA5, does not induce the unfolded
FT                   protein response in mice. No longer inhibits protein
FT                   synthesis in Vero cells. Does not induce apoptosis in Vero
FT                   cells."
FT                   /evidence="ECO:0000269|PubMed:15226357,
FT                   ECO:0000269|PubMed:17024087, ECO:0000269|PubMed:18005237,
FT                   ECO:0000269|PubMed:18433465, ECO:0000269|PubMed:19380466"
FT   HELIX           26..30
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           34..38
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          47..53
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          65..70
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           84..98
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          100..103
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           125..134
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          143..151
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           160..172
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   TURN            188..190
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           207..211
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          215..221
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   TURN            244..246
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          248..252
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          254..259
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          265..268
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           271..288
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           294..304
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   STRAND          305..307
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           309..311
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   TURN            312..314
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           323..331
FT                   /evidence="ECO:0007829|PDB:2IY9"
FT   HELIX           335..339
FT                   /evidence="ECO:0007829|PDB:4BWG"
SQ   SEQUENCE   347 AA;  37494 MW;  708D010B14790B40 CRC64;
     MLKILWTYIL FLLFISASAR AEKPWYFDAI GLTETTMSLT DKNTPVVVSV VDSGVAFIGG
     LSDSEFAKFS FTQDGSPFPV KKSEALYIHG TAMASLIASR YGIYGVYPHA LISSRRVIPD
     GVQDSWIRAI ESIMSNVFLA PGEEKIINIS GGQKGVASAS VWTELLSRMG RNNDRLIVAA
     VGNDGADIRK LSAQQRIWPA AYHPVSSVNK KQDPVIRVAA LAQYRKGETP VLHGGGITGS
     RFGNNWVDIA APGQNITFLR PDAKTGTGSG TSEATAIVSG VLAAMTSCNP RATATELKRT
     LLESADKYPS LVDKVTEGRV LNAEKAISMF CKKNYIPVRQ GRMSEEL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025